Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Zhongzhi Pharmaceutical Holdings Limited

中 智 藥 業 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 3737)

NOTIFICATION OF BOARD MEETING

The board of directors (the "Board") of Zhongzhi Pharmaceutical Holdings Limited (the "Company") hereby announces that a meeting of the Board will be held at Unit 10B, 15/F, Cable TV Tower, 9 Hoi Shing Road, Tsuen Wan, New Territories, Hong Kong on Wednesday, 26 August 2020 for the purpose of, inter alia, considering and approving the unaudited interim results of the Company and its subsidiaries for the six months ended 30 June 2020 and the payment of an interim dividend, if any.

By order of the Board

Zhongzhi Pharmaceutical Holdings Limited

Mr. Lai Zhi Tian

Chairman and Executive Director

Hong Kong, 14 August 2020

As at the date of this announcement, the Board comprises nine directors. The executive directors are Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Cao Xiao Jun and Mr. Cheng Jin Le. The non-executive directors are Ms. Jiang Li Xia and Mr. Yang Ai Xing. The independent non-executive directors are Mr. Ng Kwun Wan, Mr. Wong Kam Wah and Mr. Zhou Dai Han.

Attachments

  • Original document
  • Permalink

Disclaimer

Zhongzhi Pharmaceutical Holdings Ltd. published this content on 14 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 August 2020 08:32:01 UTC